The ES for IL‐33‐up‐regulated signatures also showed enrichment with asthma severity in sputum (Figure 2E‐H) with significant enrichment for SAns (p < 0.0001) and MMA (p < 0.01) compared with HC for the IL‐33 mast cell signature (Figure 2E). Here, IL33 is linked to asthma.